FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 2172904 · Received July 22, 2011

Report

Report Number
2124215-2011-10002
Event Type
Injury
Date Received
July 22, 2011
Date of Event
May 25, 2011
Report Date
June 9, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
PMA / PMN Number
P960040
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

ATTEMPTS TO RETRIEVE ADDITIONAL INFORMATION HAVE BEEN MADE. AT THIS TIME THERE IS NO ADDITIONAL INFORMATION AVAILABLE. IF ADDITIONAL INFORMATION BECOMES AVAILABLE THIS REPORT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION RECEIVED FROM THE PATIENT'S DEVICE FOLLOWING CLINIC INDICATED THE PATIENT HAS HAD SOME EPISODES OF VENTRICULAR TACHYCARDIA WITH A RATE OF 145 BPM. THE EPISODES HAVE NOT LASTED LONGER THAN ONE MINUTE AND NO THERAPIES WERE DELIVERED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. IF ADDITIONAL INFORMATION BECOMES AVAILABLE THIS REPORT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) EXPERIENCED A SYNCOPAL EPISODE. NO ADDITIONAL ADVERSE PATIENT EFFECTS HAVE BEEN REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 55 YR Life Threatening 1861| 4087| 0158| E110